Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone injection to inferior nasal turbinates during rhinoplasty for allergic rhinitis
IRCT20171008036655N2Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of triamcinolone acetonide in allergic rhinitis (AR) (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Effect of triamcinolone acetate injection on allergic rhinitis symptoms and quality of life, Change in symptom score in the triamcinolone group and 4 more. Started Dec 2017; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on IRCT20171008036655N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171008036655N2.